Verification of utilization ability of Bifidobacterium and Lactobacillus to difructose anhydride III in vitro by its hydrolases and their application in Jerusalem artichoke tuber to improve nutrition

Int J Biol Macromol. 2024 Oct 16;281(Pt 4):136634. doi: 10.1016/j.ijbiomac.2024.136634. Online ahead of print.

Abstract

The functional Difructose anhydride III (DFA-III) lacks reported utilization by special probiotics of Bifidobacterium and Lactobacillus. DFA-III hydrolase (DFA-IIIase), converting DFA-III to inulobiose, is a critical enzyme for the metabolism of DFA-III, which stands for the utilization ability of DFA-III by microorganisms. Hence, the research identified six potential DFA-IIIases from Bifidobacterium and Lactobacillus species, suggesting that DFA-III has the potential to proliferate these bacteria. Notably, the DFA-IIIase from Bifidobacterium adolescentis belonging to the human intestinal microbe exhibits a hydrolysis rate of up to 67 % for DFA-III, which is the highest among the reported DFA-IIIases to date. When DFA-IIIases were applied to Jerusalem artichokes, DFA-III, inulobiose, and fructo-oligosaccharides were significantly produced. The in vitro work indicates that Bifidobacterium and Lactobacillus have the potential ability to utilize DFA-III by DFA-IIIases. Moreover, the first application of DFA-IIIase in Jerusalem artichokes provides valuable insights into comprehensive strategies for utilizing high-inulin agricultural products.

Keywords: Difructose anhydride III; Difructose anhydride III hydrolase; Inulin; Jerusalem artichoke.